ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 170 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,576 | -31.4% | 21,633 | +7.5% | 0.00% | – |
| Q2 2023 | $100,016 | +4.4% | 20,124 | +3.7% | 0.00% | – |
| Q1 2023 | $95,826 | -31.3% | 19,398 | -12.5% | 0.00% | – |
| Q4 2022 | $139,518 | -38.0% | 22,181 | +6.2% | 0.00% | -100.0% |
| Q3 2022 | $225,000 | -7.4% | 20,884 | -2.2% | 0.00% | 0.0% |
| Q2 2022 | $243,000 | -8.6% | 21,359 | -26.9% | 0.00% | 0.0% |
| Q1 2022 | $266,000 | -51.5% | 29,221 | -20.5% | 0.00% | 0.0% |
| Q4 2021 | $549,000 | -47.7% | 36,775 | -9.9% | 0.00% | -66.7% |
| Q3 2021 | $1,050,000 | -11.5% | 40,837 | -10.2% | 0.00% | 0.0% |
| Q2 2021 | $1,186,000 | -4.3% | 45,476 | +29.5% | 0.00% | -25.0% |
| Q1 2021 | $1,239,000 | +41.1% | 35,111 | +1.0% | 0.00% | +33.3% |
| Q4 2020 | $878,000 | -22.8% | 34,779 | +15.3% | 0.00% | -40.0% |
| Q3 2020 | $1,137,000 | -4.0% | 30,152 | +9.0% | 0.01% | -16.7% |
| Q2 2020 | $1,184,000 | +204.4% | 27,659 | +38.4% | 0.01% | +100.0% |
| Q1 2020 | $389,000 | -54.4% | 19,992 | -39.1% | 0.00% | -25.0% |
| Q4 2019 | $853,000 | – | 32,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |